27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress
October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Home



TWENTY-SEVENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGESS DEBRIEF

Click here to review the Congress Debrief.

We are pleased to share the attached 2026 Congress Debrief, independently prepared by Amy Pawlowski of Strategic Versatility. The report highlights key themes, insights, and takeaways from this year’s presentations and discussions. Please note that this report reflects the independent observations and interpretations of its author and has not been prepared, reviewed, or endorsed by Global Health Care, LLC or the Pharmaceutical Compliance Forum (PCF).


FEATURING A C-SUITE CONGRESS VIDEO WELCOME

Albert Bourla, DVM, PhD

Chairman & CEO, Pfizer; Co-Chair, Partnership for New York City; Former Chair, Pharmaceutical Research & Manufacturers of America (PhRMA); Former President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), New York, NY


AND GOVERNMENT KEYNOTE SPEAKERS

Jacob Foster, JD

Deputy Assistant Attorney General, US DOJ; Fmr Acting Chief, Health Care Fraud (HCF) Unit, Criminal Division, Fraud Section, US DOJ; Fmr Trial Advocacy Project Deputy District Attorney, Los Angeles County District Attorney’s Office, Washington, DC

Veronika Peleshchuk Fradlin, MPP

Director, Open Payments Data Group (OPDG), Office of Enterprise Data and Analytics (OEDA), Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Washington, DC

Brenna Jenny, JD, MPH

Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US Department of Justice, Washington, DC

Twyla Mosey, PharmD, RPh

Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Washington, DC

Nicholas C. Perros, JD

Senior Trial Counsel, Civil Division, Fraud Section, US DOJ, Washington, DC

Mary E. Riordan, JD

Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC


NEW THIS YEAR:
5 IN-DEPTH, HALF-DAY, AFTERNOON FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13

(Included in your Congress registration.)

  • Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
  • Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
  • Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
  • Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
  • Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today’s Evolving Pricing & Contracting Landscape


    • FEATURING ADVAMED, BIO & PHRMA UPDATES BY

    John Delacourt, JD

    Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Fmr Chief Antitrust Counsel, FTC, Washington, DC

    Ida Nassar, JD

    Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Fmr Senior Attorney, Office of Chief Counsel, US DEA, Washington, DC

    Julie Ritchie Wagner, JD

    Assistant General Counsel, PhRMA; Fmr Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC


    ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

    Peter Agnoletto, CPA

    Compliance Officer, General Medicines and Consumer Health Care, Sanofi, Bridgewater, NJ

    Kaoutar Afif

    Manager, Ethics & Compliance, Cardinal Health, Dublin, OH

    Brian C. Barry, JD

    Vice President, Chief Compliance Officer, Vertex; Former Compliance Officer, US & Canada, EMD Serono, Boston, MA

    Devin Bates

    Global Director, Compliance Operations, Life Sciences, Danaher Corporation; Former, Director of Compliance, Walgreens, Chicago, IL

    Jennifer Beaudoin, CFE, CPA

    Executive Director, Head of Global Compliance Program Strategy, Governance & Transformation, Vertex, Boston, MA

    Loren Becher, MPH

    Executive Director, Ethics & Compliance, Knoa Pharma; Fmr Sr Director, Ethics, Compliance & Risk Enterprise Programs, Emergent, Rye Brook, NY

    Allison Benkert, MBA

    Sr. Director, Compliance Policies, Training & Investigations, Jazz, Doylestown, PA

    Amy Bentsen, JD

    Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA

    Brent Boeckmann, MBA

    Strategic Advisor, Commercial Immunology, Sanofi; Fmr VP, Eli Lilly – Inproteo Affiliate, Boston, MA

    Siyka Bozadjieva-Galiova, JD

    Global Data and Privacy Senior Advisor, Medtronic, Minneapolis, MN

    Peter Brensilver, JD

    Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY

    Terra Buckley, JD

    Senior Vice President, Chief Compliance & Ethics Officer, Bristol Myers Squibb; Fmr CCO, LivaNova, Summit, NJ

    Sri Burra, MBA

    Director, US Ethics & Compliance, Organon US; Fmr Ethics & Compliance Lead, NA, Haleon, Malvern, PA

    Briana Cabrera, MS, CFE

    Senior Director, Global Privacy & Compliance, Medtronic; Fmr Director, Forensic Audit, Covidien, Miami, FL

    Bobby Carnathan

    Senior Manager, Ethics & Compliance Business Partner, Novo Nordisk, Plainsboro, NJ

    Regina Cavaliere, JD

    Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY

    Maureen Cawley, JD

    Senior Director, Corporate Counsel, Incyte; Fmr Global Agreements Attorney, Merck, Philadelphia, PA

    Jessica Constant, MS

    Associate Director, Compliance, AstraZeneca; Fmr Global Compliance, QIAGEN, Washington, DC

    Elizabeth Conti, JD

    Senior Legal Counsel, Nestlé Health Science, Arlington, VA

    Christopher Corallo

    CCO, KARL STORZ; Fmr Interim Global CCO, Convatec; Fmr Sr Manager, Global Compliance Training, Intercept, Stanhope, NJ

    Emily Cunningham

    Associate Director, Compliance, Ultragenyx, New York, NY

    Adriana Davies, JSM

    VP, Compliance & Privacy, US & China, Smith+Nephew, Jacksonville, FL

    Giulia Del Cane, MS

    Head, E&BI Projects & Compliance Officer, Enabling Functions, Global Specialty Care, Sanofi, Boston, MA

    Sarah diFrancesca, JD

    Head of US Compliance – Immunology/Dermatology, Incyte, Wilmington, DE

    Christian Dingler, CCEP

    Executive Director, Risk Management & Program Effectiveness, Insmed, Richmond, VA

    Jason DiPietro

    Associate Director, Compliance Innovation & Analytics, Lunbeck, Deerfield, IL

    Colleen Doyle, ACFE

    Senior Director, Risk Insights, Novo Nordisk; Fmr Senior Director, Compliance, Sage, Plainsboro, NJ

    Jennifer Dubas, JD

    CCO, Jazz; Fmr SVP & CCO, Concore; Fmr SVP & CCO, AmerisourceBergen, Ambler, PA

    Katherine Dyson, JD

    Head of US Compliance, Alexion; Fmr Head of Assurance, Alexion, AstraZeneca, Boston, MS

    Kevin Espinoza

    Chief Integrity & Compliance Officer, Indivior; Fmr CCO, Kaleo; Fmr SVP, Boston Scientific, Richmond, VA

    Yelena Ferreira, JD

    VP, Legal & Compliance, Pharmacosmos; Fmr Senior Director, AGC, Pacira, Morristown, NJ

    Jim Foote, MBA, CISSP

    CEO, First Ascent Biomedical; Board Member, Sepire; Board Member, NETRAVINE; Principal Security Advisor, The CSO Advisors, Beaverton, OR

    Susana Franco, MBA

    Director, Field Compliance, Lundbeck; Fmr Director, Compliance Operations, Orthofix, Dallas, TX

    Rawan Fusisi

    Director, Integrity & Compliance, Indivior; Fmr Transparency and Analytics Manager, Stryker, Washington, DC

    Julian Gabbard, JD

    Associate GC, Meso Scale; Fmr Head of Legal & Compliance, Kolon; Fmr Sr. Director, Arcellx, Washington, DC

    Naveen Ganesh, MA, JD

    VP, Global Head of Investigations, Takeda; Fmr Head of Investigations, North America & Global Specialty Care, Sanofi, Boston, MA

    Jeanille Gatta, MA

    Director, Compliance Business Partner, AstraZeneca, North America, Philadelphia, PA

    Lindsey LaMoria Gavin

    Senior Director, Deputy Compliance Officer, Lundbeck; Fmr Compliance Director, Meetings & Events International, Deerfield, IL

    Rakan F. Ghubej, JD

    Senior Director, Senior Corporate Counsel & Assistant Corporate Secretary, Kyowa Kirin, New York, NY

    Jim Gibney

    Vice President, Global Compliance Operations, Regeneron; Fmr Director, Worldwide Programs, Pfizer, Ridgewood, NJ

    Jillian A. Gillespie, MBA

    Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Fmr Director, Compliance Business Partner, Seagen, Chicago, IL

    Betania Glorio, JD

    Fmr SVP & CCO, Avidity; Fmr CCO & Head, Group Compliance & Data Privacy, EMD Serono, Boston, MA

    Kate Godfrey, JD, CCEP

    SVP, Global Chief Compliance Officer, Karl Storz North America, El Segundo, CA

    Kimberly Gold, JD

    CPO & Senior AGC, Privacy Law, Genentech; Fmr Privacy Secondee, Pfizer, San Francisco, CA

    Carly Greenberg, JD

    Vice President, Risk Assessment, Monitoring, Governance & Legal Operations, Pfizer, New York, NY

    Edmund Greenidge JD, LLM, CCEP

    Senior Director, Compliance, Summit; Fmr R&D Ethics & Compliance Lead, Takeda, Menlo Park, CA

    Michele Guerino, MS

    Executive Director, Ethics and Compliance Officer, Merck; Fmr Senior Regional Business Director, Cubist, Hopewell, NJ

    Tracey Hannon, JD

    Director, Compliance Business Partner, Alexion, AstraZeneca Rare Disease; Fmr Compliance Counsel, Ionis, Boston, MA

    Kathryn Harris, JD

    Head, US Compliance, Galderma; Fmr Senior Director, Global Compliance, Emergent, Boston, MA

    Laura E. Heyduk

    VP, Head of Global Compliance, KalVista; Fmr Head, US Compliance, Biogen, Cambridge, MA

    Tom Hiney, JD

    Head, Digital Ethics, US Business Unit, Takeda; Fmr Privacy Counsel, Blueprint, Boston, MA

    Rachael Hu MS, MPP

    Data Privacy Senior Compliance Program Manager, Medtronic, Santa Clara, CA

    Marla Izbicky, JD

    Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL

    Denis Jacob

    Ethics & Compliance Americas Regional Leader, Solventum; Fmr Head of Compliance Audit & Investigations, GE, New York, NY

    Tahvia Jenkins, JD, CIPPUS

    US Privacy Officer & Counsel, Sanofi; Fmr Assistant Counsel, University of California, Cambridge, MA

    Kathy Johnson, JD

    Vice President, Commercial and Development Legal, Vertex; Fmr, US Legal Counsel Consultant, Takeda, Boston, MA

    Abe Kassis, MBA, PhD

    Global Head Compliance & Legal, Bausch + Lomb; Fmr Global Compliance Director, Takeda, New York, NY

    Geeta Kaveti, MHA, JD

    CCO & US General Counsel, Nyxoah; Fmr VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL

    Jeffrey Kawalek, MBA

    Chief Compliance Officer, Zambon US; Fmr Deputy CCO US, Jazz; Fmr Board Chair, PCF, New York, NY

    Jonathon L. Kellerman

    EVP, Global Chief Compliance & Privacy Officer, Global Head of Business Transformation, Bausch + Lomb; Fmr EVP & Global CCO, AbbVie, Bridgewater, NJ

    Peggy Kruk, HMCC

    Senior Manager, Compliance & Transparency, MIMEDX; Fmr Director, Compliance, Program Services, Vaniam Group, Dallas, GA

    George Kuri

    Fmr Area Business Leader, Novartis Oncology; Former District Sales Leader, Uro-Oncology/GI, Ferring Pharmaceuticals, Atlanta, GA

    Cheryl Lee, MBA, CHC

    Head of Compliance, Cycle; Fmr VP, ESG Strategy & Execution, BMS; Fmr VP, Compliance Worldwide, Celgene, New York, NY

    Aaron Lewis, MBA

    Director, Legal & Compliance, Cordis; Fmr Director, Compliance Insights, Cardinal Health, Miami Lakes, FL

    Melissa T. Lozner, JD

    Senior VP, CCO, Regeneron; Fmr CCO, Rafael Holdings; Fmr VP, Ethics, Novartis, Tarrytown, NY

    Christian Malias, MBA

    Assoc. Director, Compliance Program, Insmed; Fmr Assoc. Director Compliance, Sage, Pittsburgh, PA

    Danielle Manner, JD

    Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Fmr Senior Privacy Counsel, Pfizer, Chicago, IL

    Aaron P. Maskery, CPA

    Senior Director, Compliance Operations, Mighty; Fmr Director, Compliance Auditing & Monitoring, Idorsia, Wilmington, DE

    Rosemary McKenna, JD

    Executive Director, Regulatory Legal, Organon; Fmr Director, Regulatory-Legal, Merck, Philadelphia, PA

    Nick Merker, JD

    Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN

    Fabiana Morette-Lattea, LLM, LLB

    Global Compliance Program Lead, Telix; Fmr Associate Director, Compliance, Merck, Fishers, IN

    Michael Morgan, MBA

    Global Compliance Officer, Telix; Fmr Ethics and Compliance Officer-North America, Corteva, Indianapolis, IN

    Daniel S. Murdock, MBA, JD

    Associate General Counsel, Sobi – Swedish Orphan Biovitrum AB (publ); Fmr Associate GC – Life Sciences, McKinsey & Co; Fmr Assistant GC, Indivior, Washington, DC

    Michelle Murphy

    Executive Director, Compliance, Regeneron; Former Consultant, Musculoskeletal Transplant Foundation, New York, NY

    Meghan Naas, MA

    Senior Director, Head of Compliance, Innoviva Specialty Therapeutics; Fmr Head of Corporate Compliance, Adaptimmune, Waltham, MA

    Eric Nichols, JD

    Associate VP, Ethics & Compliance, R&D and Business Development, Eli Lilly and Company, Indianapolis, IN

    Eric Ortman, MBA

    Senior Director, Legal Operations Compliance, 4D Molecular; Fmr Senior Director, Legal Operations, BeiGene, Walnut Creek, CA

    Alison Page, JD

    Assistant General Counsel, Pfizer, New York, NY

    Al Park

    Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Fmr Global Program Effectiveness, Amgen, Phoenix, AZ

    Sandra Park, JD

    Senior VP, Legal & CCO, Vera; Fmr GC & CCO, IDEOlogy Health; Fmr VP, Commercial Legal, Kite, Brisbane, CA

    Joseph Philipose, JD

    Fmr VP, Chief Ethics & Compliance Officer, Emergent BioSolutions; Fmr VP, Alexion Pharmaceuticals; Fmr US Compliance Officer, Salix Pharmaceuticals, Boston, MA

    Samantha Brabant Philis, CCEP

    Director, E&C Policy, Training & Business Operations, Jazz; Fmr Sr Manager, Office of Ethics & Compliance, Medline Industries, Chicago, IL

    Joan Podleski, CCEP, CHPC, CHRC, CHC

    VP & CPO, Children’s Health System of Texas; Fmr Director, Compliance Program, Duke, Dallas, TX

    Perri Pomper, JD

    VP, Compliance, Stryker; Fmr VP, Compliance & Legal Affairs, Clinical Genomics, New York, NY

    Lauren Ann Pond, JD

    Assistant General Counsel, BridgeBio; Fmr Commercial Counsel, Biogen, Palo Alto, CA

    Erin B. Pulice, JD

    Litigation & Investigations Counsel, Medtronic, Minneapolis, MN

    Hannah Putnam, MHA

    Head of Ethics & Compliance Operations, Oncology, Takeda; Fmr Senior Director, Veloxis, Cambridge, MA

    Ariadna Quesada, MSJ

    VP, Compliance, Global Compliance & Privacy, ZOLL; Fmr Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain

    Omar Richardson, MBA

    Executive Director, Compliance, Shionogi; Fmr Compliance Officer, Grünenthal, New York, NY

    Roberta Rima, MS

    VP, Global Compliance Audit, Monitoring & Analytics, Zimmer Biomet; Fmr Sr Director, Gilead, San Francisco, CA

    Megan Roberts, CPA, MS

    Head, Integrity & Compliance, Par Health; Fmr Senior Director, Integrity, Mallinckrodt, St. Louis, MO

    Jaya Saigal

    Sr Dir, Compliance Training, Revolution Medicines; Fmr Sr Dir, C&E Policy, Education, Communications, Culture of Integrity & Ombuds, Bristol Myers Squibb, Redwood City, CA

    Monica Schroeter, CPA, CISA

    VP, Head of Compliance, F2G; Fmr Head of Compliance Operations & Risk, LivaNova; Goshen, NY

    Christian Scognamillo, JD

    Associate GC, US Market Access & Pricing, Abbvie; Fmr Senior Corporate Counsel, Market Access, Exelixis, San Francisco, CA

    Terri C. Segura, JD

    Global Chief Compliance Officer, LivaNova; Former Vice President, Compliance Officer – Americas, Chevy Chase, MD

    Alexis Shaw

    VP, Head of Healthcare Compliance, Paratek; Fmr Global Compliance Investigations, Boston Scientific, King of Prussia, PA

    R. Brett Short, CHC, CHPC, CHRC

    VP, CCO/CPO and Data Security Compliance Officer, Office of Corporate Compliance, UK Healthcare; Past Chair, Health Care Compliance Association, Lexington, KY

    Jesse Siegel, JD

    Head of Business Ethics, Americas, Ipsen; Fmr Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA

    Kershwin Singh, Esq.

    Compliance & Legal Executive, Fmr Head of Privacy & Compliance, ACT, ZOLL Medical; Sr Corporate Counsel, Pfizer, Avon, CT

    Jerel Smith, MSJ

    CCO-Director, Integrity & Compliance, Upsher-Smith; Fmr Director, Compliance Operations, Karyopharm, New York, NY

    Matthew Stasiunas

    RAMP & Project Management Lead, Indivior; Fmr Senior Specialist, Integrity & Compliance, Kaléo, Richmond, VA

    Ronald Strauss, CIPM

    Vice President Compliance, MiMedx; Fmr Sales Leader, Eli Lilly Specialty, Marietta, GA

    John Tao, JD

    Digital Ethics & Data Privacy Officer, Oncology, Takeda, Cambridge, MA

    Lauren H. Thal

    VP, Compliance, Tolmar; Fmr Compliance Officer, Cerapedics; Fmr Senior Director, Compliance, Beta Bionics, Chicago, IL

    Kelly J. Tope, JD, MBA

    Head, Ethics & Business Integrity Governance, Sanofi; Fmr Head, USBU Ethics & Compliance, Takeda, Boston, MA

    Emily Treanor, JD

    Head of Global Investigations, Alnylam; Fmr Senior Legal Counsel, Global Compliance, Hess, Washington, DC

    Natasha Trifun, JD

    Compliance & Risk & Privacy, AstraZeneca; Fmr Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA

    Akosua Tuffour, JD

    Corporate Counsel, U.S. General Medicines, Sanofi, Washington, DC

    Maria Villanueva, MBA

    Director, Ethics & Compliance, BioTissue; Fmr VP, Compliance Officer & Head of HR, Ra Medical Systems; Fmr Director, Compliance, Zimmer Biomet, Miami, FL

    Betsy Wade, MPH

    President, eitic healthcare compliance solutions; Faculty, Health Care Compliance Association Basic Compliance Academy and Privacy Academy, HCCA, Louisville, KY

    Achsah Warren, MSJ

    Vice President Compliance, Sumitomo; Fmr Vice President Compliance, Urovant; Fmr Senior Compliance Manager, Allergan, Irvine, CA

    Kelly Willenberg, MBA

    Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

    Elizabeth Weiss, JD

    VP, Chief Compliance & Privacy Officer, Invivyd; Fmr Head of Compliance for Americas & EMEA, Lupin, Livingston, NJ

    Amy Wilson, MBA, MSJ

    VP & CCO, Esperion; Fmr Head of US Compliance, MorphoSys; Fmr Director, Enterprise Compliance, Alexion, Boston, MA

    Suki Wiltman

    VP, Global Ethics & Compliance, Ipsen; Fmr Business Partner, Ethics & Compliance, GSK, Toronto, Canada

    Stacy E. Yeung, JD

    VP & GC, SELLAS; Fmr Assistant General Counsel, Arena Pharma; Fmr Deputy General Counsel, DBV Technologies, New York, NY

    Olga Zinavenka, CPA, MBA

    Head of Compliance Operations, Keenova; Fmr Executive Director, Head of Compliance Operations, Endo, Paoli, PA


    FORMER GOVERNMENT OFFICIALS

    Corey R. Amundson, JD

    Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC

    Jennifer L. Bragg, JD

    Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC

    Hui Chen, JD

    Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI

    Deborah A. Curtis, JD

    Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC

    Greg Demske, JD

    Partner, Goodwin Procter; Fmr Chief Counsel, Office of Inspector General, US HHS, Washington, DC

    David J. Derusha, JD

    Assistant General Counsel, Vertex; Former AUSA, US Attorney’s Offices Office, District of Massachusetts, US DOJ, Boston, MA

    Edward Diskant, JD

    Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY

    Sarah A. Franklin, JD

    Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Fmr Attorney, US FTC, Washington, DC

    Gregory T. Garcia

    Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Fmr Assistant Secretary for Cybersecurity, US DHS, Washington, DC

    Christine Gordon, JD

    VP, Risk, Assurance, & Compliance and CCO, Olympus; Fmr Assistant District Attorney, Philadelphia DA’s Office, Bethlehem, PA

    Adam Greene, JD, MPH

    Partner & Co-chair, HIPAA Practice, Davis Wright Tremaine; Fmr Senior HIT & Privacy Specialist, OCR, HHS, Washington, DC

    Kristie Gurley, JD

    Partner Covington & Burling; Fmr Counsel, Office of the General Counsel, CMS Division, US Department of HHS, Washington, DC

    Sarah M. Hall, JD

    Partner, Member of the Firm, Epstein Becker Green; Fmr Trial Attorney, Fraud Section, Criminal Division, US DOJ, Washington, DC

    Felecia Heimer, JD

    Head of Rare Disease Compliance, Worldwide Compliance & Business Ethics, Amgen; Fmr Deputy Chief & Sr Attorney, OIG, HHS, Washington, DC

    Christina Hud, JD

    Senior Counsel, Global Investigations, Pfizer; Fmr Health Care Fraud Acting Unit Chief, US Attorney’s Office, District of New Jersey, US DOJ, New York, NY

    Michelle Jerrett, JD

    Regional Head of Investigations & Monitoring, NA, Sanofi; Fmr AUSA, US Attorney’s Office, District of Massachusetts, US DOJ, Cambridge, MA

    Stewart Kameen, JD

    Partner, Davis Wright Tremaine; Fmr Senior Counsel, Industry Guidance Branch, OIG, HHS, Washington, DC

    Shannon Kelley, JD

    EVP, Chief Legal Officer, Madrigal; Fmr AUSA & Deputy Chief of Litigation, US Attorney’s Office District of Massachusetts, Boston, MA

    John Kelly, JD

    Partner & Chair, Healthcare Practice, Barnes & Thornburg; Fmr Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

    Barbara A. Leaf, JD

    Senior Int’l Advisor, Arnold & Porter; Fmr Special Assistant to the President; Fmr US Ambassador, UAE, Washington, DC

    Scott A. Memmott, JD

    Partner, Morgan, Lewis & Bockius LLP; Fmr Special AUSA, Criminal Division, US Attorney’s Office, Eastern District of Virginia, US DOJ, Washington, DC

    Christine Moundas, JD

    Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Fmr Analyst, OIG, US HHS, New York, NY

    Asha Natarajan, MPH, JD

    Of Counsel, Arnall Golden Gregory; Fmr Trial Attorney, Civil Fraud Section, US DOJ; Fmr Assistant US Attorney, Criminal Division, Health Care Fraud, US Attorney’s Office Southern District of Texas, Washington, DC

    Preeya Noronha Pinto, JD

    Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC

    Kenneth A. Polite, Jr, JD

    Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC

    Lisa M Re, JD

    Partner, Life Sciences, Arnold & Porter; Fmr Assistant Inspector General for Legal Affairs, OIG, US HHS, Washington, DC

    Angela Schwartz, JD

    Senior Principal, Global Commercial Compliance Consulting Leader, IQVIA; Fmr Special Assistant District Attorney, Montgomery County DA’s Office, Philadelphia, PA

    David J. Scott, MS

    Managing Director, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA

    Diane Seol, JD

    Of Counsel, Choate Hall & Stewart; Fmr AUSA, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

    Gregg Shapiro, JD

    Founder, Gregg Shapiro Law, LLC; Fmr Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

    Michael L. Shaw, JD

    Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ

    Amanda Strachan, JD

    Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

    Julie K. Taitsman, MD, JD

    Managing Director, BDO, US; Fmr CMO, HHS OIG; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC

    Robert M. Thomas, Jr.

    Principal, Whistleblower Law Collaborative; Fmr AUSA, US Attorney’s Office, District of Maryland, Boston, MA

    Jane H. Yoon, JD

    Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY

    Heather Young, JD

    Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA


    COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

    Warren T. Allen II, JD

    Principal, Miles & Stockbridge, Washington, DC

    David Amendola

    Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY

    Eliza L. Andonova, JD

    Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC

    Minna Bak, MBA

    Managing Director, HELIO, Boston, MA

    Brett Barlag, MBA

    Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

    Samantha Barrett Badlam, JD

    Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

    Yogesh Bahl, MBA

    Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

    Kristiana Bankova, MS

    Senior Manager, Forensics and Integrity Services, EY, New York, NY

    Daryl Berke, MPH, JD

    Assistant General Counsel, Specialty Care Market Access Lead, Sanofi, Washington DC

    Melissa Bianchi, JD

    Partner and Leader, Firm’s Digital Health Initiative, Hogan Lovells Cadwalader, Washington, DC

    Andrew Blasi, MBA

    Founder & CEO, Ethicist Int’l; Founding Member, Anti-Corruption Leaders Hub, OECD, Washington, DC

    Craig B. Bleifer, JD

    Partner, McGuire Woods; Fmr Corporate VP, GC North America; Novo Nordisk, New York, NY

    Brian A. Bohnenkamp, MHA, JD

    Partner, FDA and Life Sciences, King & Spalding, Washington, DC

    Eric Bolesh

    Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

    Simonne Brousseau, JD

    Associate, Privacy and Life Sciences Research, Faegre Drinker, Washington, DC

    Katherine Buckley, MBA

    Partner, Pharmaceutical & Life Sciences Risk & Regulatory Consulting Solutions, PwC; Philadelphia, PA

    Mary Capizzi, JD, MBA

    Partner, Faegre Drinker; GC, International Pharmaceutical & Medical Device Privacy Consortium, Washington, DC

    Matthew Chandler, JD

    Director, Epsilon Life Sciences, Richmond, VA

    Michael Clarke, JD, CCEP, NACD.DC®

    Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ

    Chris Cobourn, MS

    Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL

    Benjamin Correa, JD

    Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

    Zachary Coseglia, JD

    Co-Founder, Culture. Data. Ethics; Fmr VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

    Clarissa Crain

    Managing Director, Deloitte, Phoenixville, PA

    Kari Czeszewski, CHC

    Associate, Epsilon Life Sciences, New York, NY

    Mike D’Alessandro, CFE

    Senior Manager, Forensics & Integrity Services, EY; Fmr Chief Ethics & Compliance Officer, ahma, New York, NY

    Jamie E. Darch, JD

    Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL

    Meena Datta, JD

    Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

    Mahnu V. Davar, MA, JD

    Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

    Forrest Deegan, JD

    Principal Consultant, Spark Compliance Consulting; Co-Chair, Corporate Compliance Subcommittee, ABA, Columbus, OH

    Audrey DeGuarde, MSJ

    Vice President, General Manager, Commercial Compliance, Medispend, Morristown, NJ

    A.D. Detrick

    Measurement & Analytics Consultant, Tier1 Performance, Covington, KY

    Dominick P. DiSabatino, JD

    Partner, Life Sciences Practice, Sheppard Mullin Richter & Hampton LLP, Washington, DC

    Stefanie A. Doebler, JD

    Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

    Joy Dowdle, JD

    Partner, Litigation Department, Paul Hastings and Co-Chair of the Houston Office, Houston, TX

    Avia M. Dunn, JD, MBA

    Partner, Skadden, Arps, Slate, Meagher & Flom LLP, Washington, DC

    Kip Ebel, MBA

    Principal, Forensic & Integrity Services, EY, New York, NY

    Ronnie H. Feldman

    Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

    Alison J. Fethke, JD

    Member, Epstein Becker Green; Fmr Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL

    David Fisher, MS

    President, TDI Solutions; Fmr VP & General Manager, Cyber Innovations, Battelle, Washington, DC

    Andree-Anne Fournier, MA

    Managing Principal, Analysis Group, Brookline, MA

    Sara K. Frank, JD

    Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

    Gary F. Giampetruzzi, JD

    Partner & Global Chair Life Sciences, Paul Hastings; Fmr VP & AGC, Head of Government Investigations, Pfizer, New York, NY

    John Gitas, MBA

    Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY

    Noah C. Goldstein, JD

    Counsel, Pharma, Biotech & Medical Device Legal, Regulatory, & Compliance, Porzio Bromberg & Newman, Westborough, MA

    Ignatius Grande, JD

    Of Counsel, Winston Taylor, New York, NY

    Anthony Greco, MBA

    Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA

    Asha Green, JD, MPA

    Director, US Compliance, Ferring; Fmr Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ

    Neeraj Gupta, MBA

    President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

    Kris Hall, JD, CIPP/CIPM

    Managing Director, Dovetail; Fmr VP, Chief Privacy Officer, Celgene; Fmr VP, Head of Privacy, Shire, Bridgton, ME

    Saul B. Helman, MD, MBA

    President & Managing Director, Epsilon Life Sciences, Chicago, IL

    Kristin M. Hicks, JD

    Partner, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

    Emily F. Hodge, JD

    Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

    Casey J. Horton, CFE

    Managing Director, Epsilon Life Sciences; Fmr Director, Compliance Operations, AbbVie, Chicago, IL

    Jeff Hyre

    Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO

    Mary A. Inman, JD

    Partner, Whistleblower Partners; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA

    Katie Jacyna

    Vice President, Chief Product Officer, HELIO, Denver, CO

    Mark A. Jensen, JD

    Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

    Erin Brown Jones, MA, JD

    Partner, Latham & Watkins, Washington, DC

    Tony Jordan

    Partner, EY; Fmr Accounting Branch Chief – Boston District Office, US Securities and Exchange Commission, Boston, MA

    Marci Juneau, MBA

    A Founding Partner, Helio Health Group, Atlanta, GA

    Kristin Koehler, JD

    Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC

    Olivia Krzeminski, JD

    Director of Compliance & Legal Research, G&M Health, Somerset, NJ

    Rebekah Latchis, JD

    VP, Risk Intelligence & Investigations, Medtronic, Washington, DC

    Stephanie Lewko, CFE

    Managing Director, Healthcare Risk Management & Advisory, FTI Consulting, Washington, DC

    Scott S. Liebman, JD

    Partner, Chair, FDA Regulatory & Co-Chair, Life Sciences Practice, Sheppard Mullin Richter & Hampton LLP, New York, NY

    Courtney Lyles

    Manager, Privacy and Data Protection, Dovetail Consulting Group, Atlanta, GA

    Stephanie Macholtz, JD

    Faculty, Suffolk University Law School; Fmr VP, Compliance, Organogenesis; Fmr Senior Director Global Compliance, Apellis, Cambridge, MA

    Gabe Maldoff, JD

    Partner, Data, Privacy, and Cybersecurity practice, Goodwin Procter; Adjunct Professor, Maine Law School, Washington, DC

    Karen Mancera-Cuevas, DrPH, MS, MPH

    Senior Director, Research & Equity, National Health Council; Fmr Deputy Director, Illinois Department of Public Health, Washington, DC

    Rajiv Mehrotra, MS

    Senior Vice President, Data Science, HELIO, New York, NY

    Robert Melillo, JD

    Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

    Brook Mishler, RN, MSN

    Global Director of Compliance Solutions, Life Sciences, Case IQ; Fmr Compliance Officer for the Americas, Cordis, Ontario, Canada

    Juliana Jaccoud Molina, JD, LLM

    Global Compliance & Legal Exec; Fmr Global Director, Compliance, Privacy, Governance & Investigations, ZOLL, Miami, FL

    Christina Morris

    Senior Managing Director, FTI Consulting, Washington DC

    Tracy Mumpower

    Director, Life Science Revenue, Government Pricing, HELIO; Fmr Manager, Commercial Contract Admin, King, Bristol, VA

    Katherine C. Norris, MPA

    Senior Managing Director, Healthcare Risk Management & Advisory, FTI Consulting, Washington, DC

    Daniel O’Connor

    Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

    John Poulin

    Chief Technology Officer and Partner, Helio Health Group, Boston, MA

    Adam T. Oakley

    Senior Director, Potomac River Partners, Washington, DC

    Mohammad Ovais

    Founder & Board Member, qordata, Princeton, NJ

    Joshua (Josh) Oyster, JD

    Partner, Life Sciences Regulatory & Compliance Practice, Ropes & Gray; Former Counsel, Humana, Washington, DC

    Erica Powers, CHC

    Founder & CEO, Ethical Paths; Fmr VP & CCO, Sage; Fmr Director Corporate Compliance, Vertex, Boston, MA

    Saraswatha Lalitha Putcha, MA

    Chief Operations Officer, Cresen Solutions, Philadelphia, PA

    John S. Rah, JD

    Counsel and Head, Life Sciences Compliance Practice, Potter & Murdock, Potomac, MD

    Georgia Ravitz, JD

    Partner, FDA & Healthcare Regulatory, Orrick, Herrington & Sutcliffe, Washington, DC

    Nikki Reeves, JD

    Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

    Michael Reyes

    Director, Risk & Regulatory Consulting, PwC; Fmr Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX

    Brian Riewerts, MPA

    Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC

    Angela Rodin, MBA

    Principal, Global Ethics, KPMG; Fmr VP, Global Head of Investigations & Monitoring, GSK, Washington, DC

    Jennifer A. Romanski, JD

    Principal, Porzio, Bromberg & Newman, Parsippany, NJ

    Russell Rose, JD

    Managing Director, Deloitte Consulting, Dallas, TX

    Libby Rosenberry

    Senior Manager, Forensic & Integrity Services Senior, EY, Boston, MA

    Gillian M. Russell, JD

    Counsel, Government Matters & Regulation, Washington, DC

    Stephanie Santana, MPH, PMP

    Strategy Insights & Planning Manager, ZS, New York, NY

    Mark Scallon, MHA

    Principal, Risk Advisory, Life Sciences Consulting, Compliance and Ethics Market Leader, Baker Tilly, Richmond, VA

    Russell Schaefer, MBA

    Managing Director, BCG, Washington, DC

    Jeffrey Scott, JD

    Of Counsel, DLA Piper; Fmr Lead Compliance Counsel Digital, Pfizer, Philadelphia, PA

    Jordan Seiferas, MS

    Principal, Life Sciences Data Modernization, KPMG, Columbus, OH

    John Shakow, JD

    Pharmaceutical Government Price Reporting Expert; Partner, FDA & Life Sciences Practice, King & Spalding, Washington, DC

    Kala Shankle, JD

    VP, Regulatory, Healthcare Distribution Alliance, Washington, DC

    Paul Silver

    Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

    Emily (Jaffe) Singh

    Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL

    Laura A. Skinner, MBA

    Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

    Samantha Sutherland

    Director, Life Sciences Consulting Practice, Baker Tilly, New York, NY

    Ravneet Talwar, MBA

    Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY

    Tracey Tran

    Senior Manager, Forensic and Integrity Services, EY, New York, NY

    Stephanie Trunk, JD

    Partner, Life Science Practice Group, Arent Fox Schiff; Fmr Legal Counsel, Catalyst Health Solutions, Washington, DC

    Brian Van Hoy, RPh

    Vice President of Compliance, G&M Health; Fmr Director Compliance & Ethics, Eli Lilly, Somerset, NJ

    L. Stephan Vincze, JD, LLM, MBA

    President & CEO, TRESTLE Compliance; Fmr SVP & CCO, Warner Chilcot; Fmr VP & CCO, TAP, Boston, MA

    Erin Wagenberg, CIPP/US, CIPP/E, CIPT

    Director, Dovetail Consulting Group; Fmr Deputy Privacy Officer, Deloitte Global, Atlanta, GA

    Shannon Walker

    Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

    Robert A. Wells, JD

    Health Shareholder, Chair, Health Law Solutions, Baker, Donelson, Bearman, Caldwell & Berkowitz, Baltimore, MD

    Sarah L. Whipple, JD

    Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Fmr VP, GCCO, Apellis, Needham, MA

    Kelly Willenberg, MBA, DBA, CHC

    Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

    Jacob Wolf, MBA

    Chief Commercial Officer, Cresen Solutions, Orlando, FL

    Christina Woods, MHA

    Partner, Pharmaceutical and Life Sciences Risk & Regulatory Consulting, PwC, New York, NY

    Lily Zimmerman

    Learning Solution Architect, TiER1 Performance, Covington, KY

    Cobun Zweifel-Keegan, JD

    Managing Director, IAPP; Fmr Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC


    THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

    Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.



    A HYBRID CONFERENCE AND INTERNET EVENT